Gladstone-Led HIV Study Tops Time List
Gladstone-Led HIV Study Tops Time List
San Francisco Business Times—Ten years ago, an international HIV study led by then Gladstone Investigator Robert Grant, MD, MPH, showed that the antiretroviral drug Truvada taken as a prophylactic could reduce the risk of infection by HIV, a study that was declared medical breakthrough of the year by Time magazine.
Gladstone Experts HIV/AIDS